Deprescribing proton pump inhibitors in adults with stable dyspepsia without alarm features: stepped reduction vs. abrupt discontinuation
Patel NA et al. | Published: 2026-04-02 (illustrative)
AI Summary (90-second read)
Primary-care physicians often inherit long-term PPI prescriptions from acute care transitions. For adults with stable dyspeptic symptoms but no documented alarm criteria, gradual stepping down paired with reassurance and symptom diaries was associated with fewer early rebound consultations than abrupt discontinuation in cohort-style analyses—though heterogeneity remained high across practices.
The practical takeaway for busy clinics: clarify indication, revisit alarm symptoms, agree on an explicit taper when deprescribing, and document contingency plans—especially for patients already on ASA or NSAIDs—without implying Vaid MD is issuing independent medical judgment.
Key takeaways
- Structured deprescribing conversations reduce avoidable PPI continuation when alarm features are absent.
- Symptom diaries improve patient confidence during taper versus abrupt cessation.
- Canadian guidelines emphasize reassessment cycles—Pulse surfaces these themes as daily briefings.
Sample card for marketing only. Do not use for patient care. Summaries are illustrative and not a substitute for reading the full article.